EUVIMEDEUVIMED entdecken
LeitlinieÜbersichtsarbeit

Quality‐of‐Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient‐Oriented Outcomes and External Experts

Pavel V Chernyshov iD, Andrew Y Finlay, Lucia Tomas-Aragones, Francoise Poot, Dedee F Murrell iD, Nives Pustisek, Ake Svensson, Servando E Marron, Francesca Sampogna, Anthony Bewley, Carmen Salavastru, Dimitra Koumaki iD und 9 weitere

International Journal of Dermatology · 2025

DOI: 10.1111/ijd.17668 ↗

Kurz gefasst

Leitlinie in der Zeitschrift International Journal of Dermatology, 2025. Verfasst von Pavel V Chernyshov und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, National Medical University, Kyiv, Ukraine. Hauptthemen laut MEDLINE: Quality of Life, Epidermolysis Bullosa. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this paper, the European Academy of Dermatology and Venereology (EADV) Task Force on Quality of Life (QoL) and Patient‐Oriented Outcomes presents its position statements on health‐related (HR) QoL assessment in epidermolysis bullosa (EB). The EADV TF on QoL and Patient‐Oriented Outcomes recommends the use of the EB‐specific instrument QOLEB in patients over the age of 10 years and, in addition to the QOLEB, the use of iscorEB‐p in moderate‐to‐severe EB; the IntoDermQoL proxy instrument with its EB‐specific module should be used in children aged under 5 years. The EB‐specific instrument iscorEB‐p, and the dermatology‐specific instrument CDLQI may measure HRQoL in children with EB aged from 5 to 10 years. Dermatology‐specific and/or generic HRQoL instruments should be used to compare the impact on QoL of EB with other diseases; family QoL of patients with EB should be studied using the EB‐specific EB‐BoD, dermatology‐specific family measures, and/or generic family QoL instruments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeEpidermolysis BullosaHumansChildChild, PreschoolDermatologyEuropeSurveys and QuestionnairesSeverity of Illness IndexAdvisory CommitteesVenereology

Stichwörter der Autor:innen

European Academy of Dermatology and Venereologyepidermolysis bullosameasurementquality of lifetask forcetreatment

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, National Medical University, Kyiv, Ukraine.
  • Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Department of Psychology, University of Zaragoza, Zaragoza, Spain.
  • Department of Dermatology, University Hospital Erasme, Brussels, Belgium.
  • Department of Dermatology, St George Hospital, UNSW, Sydney, Australia.
  • Children's Hospital Zagreb, Zagreb, Croatia.

ORCID-Profile: Pavel V Chernyshov, Dedee F Murrell, Dimitra Koumaki, Matthias Augustin, Gregor B Jemec

Zitieren

APA

Chernyshov, P. V., Finlay, A. Y., Tomas-Aragones, L., Poot, F., Murrell, D. F., Pustisek, N., Svensson, A., Marron, S. E., Sampogna, F., Bewley, A., Salavastru, C., Koumaki, D., Suru, A., Yordanova, I. A., Zemskov, S., Tsymbaliuk, R., Ostapko, O., Augustin, M., Abeni, D., …, & Jemec, G. B. (2025). Quality‐of‐Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient‐Oriented Outcomes and External Experts. International Journal of Dermatology. https://doi.org/10.1111/ijd.17668

Vancouver

Chernyshov PV, Finlay AY, Tomas-Aragones L, Poot F, Murrell DF, Pustisek N, et al. Quality‐of‐Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient‐Oriented Outcomes and External Experts. International Journal of Dermatology. 2025. doi:10.1111/ijd.17668

BibTeX
@article{Chernyshov2025,
  author = {Chernyshov, Pavel V and Finlay, Andrew Y and Tomas-Aragones, Lucia and Poot, Francoise and Murrell, Dedee F and Pustisek, Nives and Svensson, Ake and Marron, Servando E and Sampogna, Francesca and Bewley, Anthony and Salavastru, Carmen and Koumaki, Dimitra and Suru, Alina and Yordanova, Ivelina A and Zemskov, Serhiy and Tsymbaliuk, Ruslan and Ostapko, Olena and Augustin, Matthias and Abeni, Damiano and Szepietowski, Jacek C and Jemec, Gregor B},
  title = {Quality‐of‐Life Measurement in Epidermolysis Bullosa. Position Statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient‐Oriented Outcomes and External Experts},
  journal = {International Journal of Dermatology},
  year = {2025},
  doi = {10.1111/ijd.17668}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche